DGE’s 2nd Human Factors Engineering & Usability Studies Congress To Offer An Online Educational Tour On Decentralized Medical Testing For Different User Groups

Date: September 9-10, 2021 Online Livestream Professionals and executives in pharmaceutical, biotech, and medical device companies are invited to attend DGE’s 2nd Human Factors Engineering & Usability Studies Congress being held on September 9-10, 2021. The leading industry conference will offer an educational experience on designing and testing safe and intuitive medical products for all user groups while adapting to regulatory compliance and the unpredictable post-COVID pandemic impact. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The Global Event Company caters to the dynamic informational and networking need of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries. The 2-day event will witness speeches, keynotes, and discussions from leading pharma industry professionals and clinicians. The agenda of the conference:

• FDA feedback on best practices regarding training decay for complex systems and long-travel users
• Detailed analysis on regulatory compliance with remote usability testing for virtual user platforms– both domestic and international
• Novel strategies on analyzing the human needs of wearables and home-use devices
• Ways to bridge the gaps between traditional risk analysis and FDA expectations
• A detailed study to convince management of the importance of increasing spending on human factors issues
• Tracking the impact of machine learning and artificial intelligence on medical device development and testing
• Understand and build effective digital and cloud-based systems around large system design
• Discussions on improving risk-based clinical simulation techniques while keeping the costs under control
• This is the only industry conference featuring a proven interactive streaming platform for human factor engineering and usability study

This is a crucial venue for medical device and combination product professionals to get direct feedback from FDA, and also to find solutions to usability issues while avoiding medication errors and improving the patient experience. Interactive Q&As will give project managers detailed knowledge on how to merge perspectives from diverse teams in order to meet design goals. If you are a vendor looking to offer solutions to these issues, the attendees would like to know what you have to offer – please contact Amy Chapman ([email protected] or 561-571-7687) to discuss the available options for highlighting your expertise to our audience. Don’t miss this uniquely in-depth event sharing new trends and techniques in human factors and usability! For more details about the event, please visit https://ibn.fm/2ppy9.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.